Rifaximin: A Nonabsorbed Antimicrobial in the Therapy of Travelers’ Diarrhea

Abstract

Rifaximin shortened the duration of travelers' diarrhea compared with TMP/SMX and 2 earlier studied placebo-treated groups. A poorly absorbed drug if effective in treating bacterial diarrhea has pharmacologic and safety advantages over the existing drugs.